• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Youtube
  • otv

Tag: Covid19 Drug

Centre To Examine Data Of 2-DG Drug Before Adding To National COVID Treatment Protocol
Centre To Examine Data Of 2-DG Drug Before Adding To National COVID Treatment Protocol

The drug 2-deoxy-D-glucose has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), along with Dr Reddy's Laboratories (DRL), Hyderabad.

2 DG Drug
DRDO's Anti-Covid Drug 2-DG Launched

The first batch of DRDO-developed anti-Covid drug 2-DG (2-deoxy-D-glucose) was launched on Monday to treat patients suffering from the deadly disease. The medicine comes in powder form and can be taken with water.

FluGuard
COVID-19: Sun Pharmaceutical Launches Favipiravir As FluGuard At Rs 35

New Delhi: Sun Pharmaceutical Industries Ltd on Tuesday announced the launch of Favipiravir, under brand name FluGuard, at Rs 35 per tablet for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is an oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease. […]

scrollToTop